CD8A and glioblastoma: To better comprehend the basis of resilience and durability of the CB T cell response, we subclustered our scRNA-seq data focusing on the transcriptomes of n = 18,973 CD8+ T cells collected from eight patients with glioblastoma and, as control, from five patients with nonmalignant intracranial disease (Fig. 3e, Extended Data Fig. 3d–f and Supplementary Tables 1 and 2).